*	OR T4 T5
R1	Has_value Arg1:T3 Arg2:T4	
R2	Subsumes Arg1:T3 Arg2:T7	
R3	Has_value Arg1:T10 Arg2:T11	
R4	Subsumes Arg1:T12 Arg2:T14	
R5	Has_qualifier Arg1:T16 Arg2:T15	
R6	Has_temporal Arg1:T16 Arg2:T17	
R7	Has_temporal Arg1:T12 Arg2:T13	
*	OR T19 T18
*	OR T20 T21
R8	Has_value Arg1:T24 Arg2:T25	
R9	Has_qualifier Arg1:T22 Arg2:T26	
R10	Has_qualifier Arg1:T23 Arg2:T27	
*	OR T22 T23
R11	Subsumes Arg1:T22 Arg2:T24	
R12	Has_temporal Arg1:T22 Arg2:T30	
R13	Has_qualifier Arg1:T32 Arg2:T33	
R14	AND Arg1:T32 Arg2:T34	
R15	Has_multiplier Arg1:T34 Arg2:T35	
R16	Has_negation Arg1:T38 Arg2:T37	
R17	AND Arg1:T36 Arg2:T38	
R18	Has_qualifier Arg1:T40 Arg2:T39	
R19	Has_value Arg1:T41 Arg2:T42	
R20	Has_value Arg1:T44 Arg2:T45	
R21	Subsumes Arg1:T43 Arg2:T44	
R22	Subsumes Arg1:T40 Arg2:T41	
R23	Has_value Arg1:T50 Arg2:T51	
R24	Subsumes Arg1:T49 Arg2:T50	
*	OR T40 T49 T43
R25	Has_value Arg1:T54 Arg2:T55	
*	OR T56 T57
R26	Has_context Arg1:T56 Arg2:T58	
R27	AND Arg1:T60 Arg2:T61	
R28	AND Arg1:T64 Arg2:T65	
T1	Measurement 16 30	calculated PRA
T2	Value 31 61	higher than 0% per solid phase
T3	Procedure 131 150	single antigen test
T4	Value 71 87	anti-HLA class I
T5	Value 71 79;97 105	anti-HLA class II
T7	Procedure 152 159	Luminex
T8	Procedure 220 246	graft from a cadaver donor
T9	Condition 249 262	Identical HLA
T10	Procedure 183 194	Cross Match
T11	Value 164 172	Positive
T12	Procedure 312 334	solid organ transplant
T13	Temporal 303 311	previous
T14	Procedure 346 363	kidney transplant
T15	Qualifier 393 400	another
T16	Procedure 401 423	solid organ transplant
T17	Temporal 424 437	concomitantly
T18	Condition 440 464;479 488	Glomerular primary focal sclerosis
T19	Condition 440 450;469 488	Glomerular segmental sclerosis
T20	Condition 490 531	Atypical hemolytic uremic syndrome (aHUS)
T21	Condition 534 578	thrombotic thrombocytopenic purpura syndrome
T22	Condition 618 641	Hepatitis B virus (HBV)
T23	Condition 673 690	Hepatitis C virus
T24	Procedure 701 711	PCR result
T25	Value 692 700	positive
T26	Qualifier 595 602	chronic
T27	Qualifier 651 657	active
T30	Temporal 713 738	at the time of transplant
T31	Condition 780 814	Human Immunodeficiency Virus (HIV)
T32	Condition 838 856	systemic infection
T33	Qualifier 831 837	active
T34	Drug 903 914	antibiotics
T35	Multiplier 875 899	continued administration
T36	Condition 935 943	neoplasm
T37	Negation 944 950	except
T38	Condition 951 972	localized skin cancer
T39	Qualifier 1029 1035	severe
T40	Condition 1036 1042	anemia
T41	Measurement 1044 1054	hemoglobin
T42	Value 1055 1063	<6g / dl
T43	Condition 1066 1076	leukopenia
T44	Measurement 1078 1081	WBC
T45	Value 1082 1093	<2500 / mm3
T49	Condition 1104 1120	thrombocytopenia
T50	Measurement 1122 1131	platelets
T51	Value 1132 1145	<80,000 / mm3
T53	Condition 1166 1190	hemodynamically unstable
T54	Measurement 1209 1226	hemoglobin levels
T55	Value 1226 1235	> 6g / dL
T56	Condition 1252 1272	intestinal pathology
T57	Condition 1276 1291	severe diarrhea
T58	Observation 1297 1320	may decrease absorption
T60	Condition 1373 1389	hypersensitivity
T61	Drug 1404 1428	drugs used in this study
T62	Competing_trial 1431 1537	Patients who have received any investigational drug in the 30 days prior to their inclusion in this study.
T63	Pregnancy_considerations 1539 1756	Potentially fertile women who do not agree to use reliable contraceptive measures during the trial, who are pregnant, breastfeeding or who present a positive pregnancy test at the time of their inclusion in the study.
T64	Observation 1775 1791	legally detained
T65	Visit 1798 1818	official institution
